AU7703700A - Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein - Google Patents

Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein

Info

Publication number
AU7703700A
AU7703700A AU77037/00A AU7703700A AU7703700A AU 7703700 A AU7703700 A AU 7703700A AU 77037/00 A AU77037/00 A AU 77037/00A AU 7703700 A AU7703700 A AU 7703700A AU 7703700 A AU7703700 A AU 7703700A
Authority
AU
Australia
Prior art keywords
treatment
pharmaceutical compositions
urinary tract
lower urinary
tract symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU77037/00A
Inventor
Mark A. Bach
Paul J. Drake
Elizabeth Stoner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU7703700A publication Critical patent/AU7703700A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU77037/00A 1999-09-22 2000-09-18 Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein Abandoned AU7703700A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15535799P 1999-09-22 1999-09-22
US60155357 1999-09-22
PCT/US2000/025534 WO2001021167A1 (en) 1999-09-22 2000-09-18 Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein

Publications (1)

Publication Number Publication Date
AU7703700A true AU7703700A (en) 2001-04-24

Family

ID=22555118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77037/00A Abandoned AU7703700A (en) 1999-09-22 2000-09-18 Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein

Country Status (2)

Country Link
AU (1) AU7703700A (en)
WO (1) WO2001021167A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009227918B2 (en) * 2000-02-09 2011-09-22 Aspen Global Incorporated Pharmaceutical combinations

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003026564A2 (en) * 2001-09-27 2003-04-03 Pharmacia Ab Pharmaceutical compositions for the treatment of urinary disorders
DK1501517T3 (en) * 2002-04-24 2007-06-11 Boehringer Ingelheim Pharma Pharmaceutical combination for the treatment of benign prostate hyperplasia or for long-term prevention of acute urinary retention
WO2005092341A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Combination therapy for lower urinary tract symptoms
MX2007003949A (en) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Synergic pharmaceutical compositions consisting of a combination of a 5 a-reductase enzyme inhibitor and a 1 a- adrenergic receptor antagonist.
EP2363397A4 (en) * 2008-11-07 2012-07-11 Dainippon Sumitomo Pharma Co Novel useful therapeutic agent for lower urinary tract symptom

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0760238B1 (en) * 1994-05-18 2002-04-17 Hisamitsu Pharmaceutical Co., Inc. Percutaneously administrable preparation for treating urination disorder

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009227918B2 (en) * 2000-02-09 2011-09-22 Aspen Global Incorporated Pharmaceutical combinations

Also Published As

Publication number Publication date
WO2001021167A8 (en) 2001-09-07
WO2001021167A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
HU0100586D0 (en) Pharmaceutical compositions treating lower urinary tract symptoms
AU4300701A (en) Methods and compositions for administration of therapeutic reagents
EP1600168A3 (en) A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
HU9802525D0 (en) Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
EP1240136A4 (en) Use of biologically active vitamin d compounds for the prevention and treatment of inflammatory bowel disease
AU3469400A (en) Pharmaceutical compositions for treatment of diseased tissues
AU5326100A (en) Pharmaceutical compositions and methods for use
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU2002248319A1 (en) Pharmaceutical composition for the prevention and treatment of scar tissue
AUPQ415899A0 (en) Compositions for and methods of treatment of allergic diseases
HK1067362A1 (en) Heterocyclic compounds for use in the treatment ofdisorders of the urinary tract
HUP0301460A3 (en) Use of antiprogestins for producing pharmaceutical compositions for prohylaxis and treatment of hormone-dependent diseases
HUP0303908A2 (en) Use of selective cox-2 inhibitors for preparation of pharmaceutical composition for the treatment of urinary incontinence
AU7360700A (en) Methods and compositions for preventing and treating urinary tract disorders
AU2300001A (en) Pharmaceutical compositions useful in the prevention and treatment of beta-amyloid protein-induced disease
AUPR101600A0 (en) Compositions and methods for diagnosis and treatment of cardiovascular disorders
HUP0300402A3 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain and pharmaceutical compositions containing them
AU2001285683A1 (en) Mild enrichment of foetal cells from peripheral blood and use thereof
AU7703700A (en) Treatment of lower urinary tract symptoms and pharmaceutical compositions for use therein
HUP0300860A3 (en) Pharmaceutical compositions suitable for treatment of urinary dysfunction
AU1953701A (en) Methods and compositions for treatment of inflammatory disease
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase